Antifungal susceptibility of emerging yeast pathogens (Q43664354)

25 November 2017

title

Antifungal susceptibility of emerging yeast pathogens (English)

1 reference

25 November 2017

García-Martos P

1

1 reference

25 November 2017

Domínguez I

2

1 reference

25 November 2017

Marín P

3

1 reference

25 November 2017

García-Agudo R

4

1 reference

25 November 2017

Aoufi S

5

1 reference

25 November 2017

Mira J

6

1 reference

25 November 2017

publication date

1 June 2001

1 reference

Infectious Diseases and Clinical Microbiology

25 November 2017

published in

1 reference

25 November 2017

volume

19

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

249-256

1 reference

Importance of Candida species other than C. albicans as pathogens in oncology patients

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

New and emerging yeast pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Amphotericin B-resistant yeast infection in severely immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Fluconazole resistance in Candida glabrata

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Failure of fluconazole therapy in Candida krusei fungemia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Candida albicans resistance in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Candida norvegensis: a fluconazole-resistant species.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifungal susceptibility panel

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus [...]

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Endocarditis caused by Blastoschizomyces capitatus and taxonomic review of the genus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Disseminated Blastoschizomyces capitatus infection in acute myeloblastic leukaemia. Report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Fungal urinary tract infections in patients at risk

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Blastoschizomyces capitatus infection in acute leukemia patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Torulopsis candida (Candida famata) Endophthalmitis Simulating Propionibacterium acnes Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Fatal Candida famata peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis who was treated with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Candida famata fungemia in a surgical patient successfully treated with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Candida famata fungemia in a cancer patient: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Infectious crystalline keratopathy caused by Candida guilliermondii

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Case report. Osteomyelitis caused by high resistant Candida guilliermondii

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Nosocomial Candida guilliermondii fungemia in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Osteomyelitis of the hand due to Torulopsis holmii

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

A nosocomial cluster of Candida inconspicua infections in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Oesophagitis caused by Candida kefyr

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Fungaemia survey: a 10-year experience in Bergamo, Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Candida lusitaniae: a new opportunistic pathogen of the urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Isolation of Candida norvegensis from clinical specimens: four case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Invasive Candida norvegensis infection in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Hansenula anomala infections in children: from asymptomatic colonization to tissue invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Fungemia caused by Hansenula anomala: successful treatment with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Intravenous catheter-related Candida rugosa fungaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Catheter-associated Candida utilis fungemia in a patient with acquired immunodeficiency syndrome: species verification with a molecular probe

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Chronic urinary tract infection due to Candida utilis.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Transient fungemia and Candida arthritis due to Candida zeylanoides

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Oral yeasts in patients with cancer of the mouth, before and during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Pichia ohmeri fungemia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Endocarditis caused by Rhodotorula successfully treated with 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Rhodotorula rubra peritonitis in a child undergoing intermittent cycling peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Sepsis due to Rhodotorula related to use of indwelling central venous catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Chronic postoperative Rhodotorula endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Postoperative peritonitis caused by Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Saccharomyces cerevisiae fungemia: case report and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Saccharomyces cerevisiae pneumonia in a patient with acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Saccharomyces cerevisiae empyema in a patient with esophago-pleural fistula complicating variceal sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Disseminated infection with Trichosporon beigelii

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Trichosporon beigelii, an emerging pathogen resistant to amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Yeast in blood cultures. Evaluation of factors influencing outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Evaluation of a colorimetric method for detecting amphotericin B-resistant Candida isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Fluconazole resistant candida in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

New antifungal agents and preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2801%2972630-4

7 January 2021

10.1016/S0213-005X(01)72630-4

Identifiers

DOI

1 reference

25 November 2017

1 reference